1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSION AND EXCLUSIONS 30
1.3 MARKET SCOPE 31
FIGURE 1 CLOSED SYSTEM TRANSFER DEVICES MARKET SEGMENTATION 31
FIGURE 2 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION 31
1.3.1 YEARS CONSIDERED FOR THE STUDY 32
1.4 CURRENCY 32
TABLE 1 STANDARD CURRENCY CONVERSION RATES 32
1.5 STAKEHOLDERS 33

2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 3 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 37
FIGURE 4 PRIMARY SOURCES 38
2.1.2.1 Key data from primary sources 39
2.1.2.2 Key industry insights 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 41
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION 41
2.2 MARKET SIZE ESTIMATION 42
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 42
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION 42
FIGURE 10 REVENUE ANALYSIS OF THE TOP THREE PUBLIC COMPANIES: CLOSED SYSTEM TRANSFER DEVICES MARKET (2020) 43
FIGURE 11 BOTTOM-UP APPROACH 43
FIGURE 12 TOP-DOWN APPROACH 44
FIGURE 13 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE CLOSED SYSTEM TRANSFER DEVICES MARKET (2021-2026) 45
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 46
FIGURE 15 DATA TRIANGULATION METHODOLOGY 46
2.4 ASSUMPTIONS FOR THE STUDY 47
2.5 LIMITATIONS 47
2.5.1 METHODOLOGY-RELATED LIMITATIONS 48
2.6 RISK ASSESSMENT 48
TABLE 2 RISK ASSESSMENT: CLOSED SYSTEM TRANSFER DEVICES MARKET 48

3 EXECUTIVE SUMMARY 49
FIGURE 16 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2021 VS. 2026 (USD MILLION) 49
FIGURE 17 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 50
FIGURE 18 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION) 50
FIGURE 19 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION) 51
FIGURE 20 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 52
FIGURE 21 GEOGRAPHIC SNAPSHOT: CLOSED SYSTEM TRANSFER DEVICES MARKET 53

4 PREMIUM INSIGHTS 54
4.1 CLOSED SYSTEM TRANSFER DEVICES MARKET OVERVIEW 54
FIGURE 22 THE RISING INCIDENCE OF CANCER IS DRIVING THE GROWTH OF THE CLOSED SYSTEM TRANSFER DEVICES MARKET 54
4.2 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET OVERVIEW 55
FIGURE 23 DIAPHRAGM-BASED DEVICES ACCOUNTED FOR THE LARGEST SHARE OF THE APAC CLOSED SYSTEM TRANSFER DEVICES MARKET IN 2020 55
4.3 CLOSED SYSTEM TRANSFER DEVICES MARKET: REGIONAL MIX 56
FIGURE 24 NORTH AMERICA TO DOMINATE THE MARKET THROUGHOUT THE FORECAST PERIOD 56
4.4 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
FIGURE 25 CHINA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 56
4.5 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS 57
FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD 57

5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
FIGURE 27 CLOSED SYSTEM TRANSFER DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
5.1.1 DRIVERS 59
5.1.1.1 Rising incidence of cancer 59
FIGURE 28 GLOBAL CANCER INCIDENCE (2008-2030) 59
TABLE 3 CANCER RATES, BY COUNTRY (2018) 59
TABLE 4 US: NEW CANCER CASES (2017-2020) 60
5.1.1.2 The increasing number of oncology drug approvals 60
TABLE 5 FDA APPROVALS: NOVEL PRESCRIPTION CANCER DRUGS IN 2018 60
5.1.1.3 Increasing use of CSTDs to combat the harmful effects of cytotoxic or antineoplastic drugs 61
5.1.1.4 Growing emphasis on the implementation of occupational health and safety standards 62
TABLE 6 LIST OF NATIONAL/LOCAL REGULATORY BODIES RECOMMENDING THE USE OF CSTDS FOR THE SAFE HANDLING OF HAZARDOUS DRUGS, BY COUNTRY 63
5.1.2 RESTRAINTS 63
5.1.2.1 High cost of implementation of CSTDs and lack of reimbursement 63
TABLE 7 AVERAGE ANNUAL COSTS ASSOCIATED WITH THE IMPLEMENTATION OF VARIOUS CSTD SYSTEMS (USD) 64
5.1.2.2 Lack of compliance with regulatory guidelines in developing countries 64
5.1.3 OPPORTUNITIES 65
5.1.3.1 Increasing application of CSTDs in other therapeutic areas 65
5.1.3.2 Increasing adoption in emerging economies due to rising healthcare expenditure 65
5.1.4 CHALLENGES 66
5.1.4.1 Gaps with existing CSTDs 66
TABLE 8 ISSUES, CHALLENGES, AND POTENTIAL SOLUTIONS REGARDING THE SAFE HANDLING OF HAZARDOUS DRUGS 66
5.1.4.2 Low awareness among nurses about CSTDs 67
5.2 PORTER'S FIVE FORCES ANALYSIS 68
TABLE 9 CLOSED SYSTEM TRANSFER DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS 68
5.2.1 THREAT OF NEW ENTRANTS 69
5.2.1.1 Growth in the medication delivery and management segment 69
5.2.1.2 Demand for safe drug compounding and handling devices 69
5.2.1.3 Highly concentrated market 69
5.2.1.4 Poor financing environment 69
5.2.1.5 Stringent regulatory environment 69
5.2.2 THREAT OF SUBSTITUTES 69
5.2.2.1 Unavailability of potential safe drug handling systems 69
5.2.2.2 Combination and integration of multiple technologies 70
5.2.3 BARGAINING POWER OF SUPPLIERS 70
5.2.3.1 Institutional technology providers 70
5.2.3.2 Substantially innovative technologies 70
5.2.3.3 Dysfunctional companies 70
5.2.4 BARGAINING POWER OF BUYERS 70
5.2.4.1 Few buyers and many sellers 70
5.2.4.2 Buy-out threat 70
5.2.4.3 Point of differentiation 70
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 71
5.2.5.1 Highly concentrated industry 71
5.2.5.2 Similar funding source 71
5.3 INDUSTRY TRENDS 71
5.3.1 AUTOMATED COMPOUNDING OF HAZARDOUS DRUGS USING ROBOTIC SYSTEMS 71
5.3.2 EMERGING TECHNOLOGIES FOR RAPID DETECTION TESTS TO FACILITATE ROUTINE MONITORING AND SAFE HANDLING OF HAZARDOUS DRUGS 72
5.4 PRODUCT FEATURES AND PRICING ANALYSIS 72
TABLE 10 COMPARATIVE ANALYSIS OF COMMERCIALLY AVAILABLE CSTDS BASED ON PRODUCT FEATURES 73
5.5 UTILIZATION/ADOPTION OF CSTDS, BY REGION 74
TABLE 11 INTENSITY OF UTILIZATION/ADOPTION OF VARIOUS TYPES OF CSTDS, BY REGION 74
5.6 REGULATORY GUIDELINES 75
TABLE 12 STRINGENCY OF REGULATIONS FOR THE ADOPTION OF CSTDS, BY REGION 75
5.6.1 USP <800> REGULATIONS 75
5.6.2 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH 76
TABLE 13 NIOSH CLASSIFICATION OF HAZARDOUS DRUGS 76
TABLE 14 NIOSH HAZARDOUS DRUG ADMINISTRATION RECOMMENDATIONS AND REQUIREMENTS 77
5.6.3 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 78
TABLE 15 NIOSH AND ASHP DEFINITIONS OF HAZARDOUS DRUGS 78
5.6.4 INTERNATIONAL SOCIETY OF ONCOLOGY PHARMACY PRACTITIONERS 78
5.7 REGULATORY ANALYSIS 79
5.8 ECOSYSTEM MAPPING 79
FIGURE 29 CLOSED SYSTEM TRANSFER DEVICES MARKET: ECOSYSTEM (2020) 79
5.9 VALUE CHAIN ANALYSIS 80
FIGURE 30 VALUE CHAIN ANALYSIS: CLOSED SYSTEM TRANSFER DEVICES 80
5.10 SUPPLY CHAIN ANALYSIS 81
FIGURE 31 SUPPLY CHAIN ANALYSIS: CLOSED SYSTEM TRANSFER DEVICES MARKET 82
5.11 PATENT ANALYSIS 82
FIGURE 32 PATENT ANALYSIS: CLOSED SYSTEM TRANSFER DEVICES MARKET 82
5.12 KEY MARKETS FOR IMPORT AND EXPORT (TRADE ANALYSIS FOR CLOSED SYSTEM TRANSFER DEVICES) 83
TABLE 16 IMPORT VALUE OF CLOSED SYSTEM TRANSFER DEVICES FOR TOP 10 COUNTRIES IN 2020 83
5.13 COVID-19 IMPACT ANALYSIS 83
5.13.1 COVID-19 HEALTH ASSESSMENT 83
5.13.2 COVID-19 ECONOMIC ASSESSMENT 84
5.13.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 84
FIGURE 33 CRITERIA IMPACTING THE GLOBAL ECONOMY 84
5.13.4 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET 85
5.14 YC-YCC SHIFT 86
FIGURE 34 YC-YCC SHIFT IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET 86

6 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM 87
6.1 INTRODUCTION 88
TABLE 17 TYPES OF CLOSING MECHANISMS IN THE CURRENTLY AVAILABLE CSTDS 88
TABLE 18 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 88
6.2 LUER-LOCK SYSTEMS 89
6.2.1 LUER-LOCK MECHANISMS REDUCE THE RISK OF EXPOSURE, REQUIRE FEWER COMPONENTS, AND GENERATE LESS BIOHAZARDOUS WASTE— KEY ADVANTAGES DRIVING GROWTH 89
TABLE 19 LUER-LOCK CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 89
6.3 PUSH-TO-TURN SYSTEMS 90
6.3.1 HIGH ADOPTION OF PHASEAL, A PIONEER IN THE CSTD MARKET— A KEY MARKET DRIVER 90
TABLE 20 PUSH-TO-TURN CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 90
6.4 CLICK-TO-LOCK SYSTEMS 91
6.4.1 THE USER-FRIENDLY NATURE OF CLICK-TO-LOCK MECHANISMS DRIVES THEIR ADOPTION AMONG END USERS 91
TABLE 21 CLICK-TO-LOCK CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 91
6.5 COLOR-TO-COLOR ALIGNMENT SYSTEMS 92
6.5.1 LOW SYSTEM COST, ALONG WITH THE ADVANTAGES OFFERED, INCREASES THE ADOPTION OF THESE SYSTEMS AMONG PHARMACISTS, ONCOLOGISTS, AND NURSES 92
TABLE 22 COLOR-TO-COLOR ALIGNMENT CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 92

7 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE 93
7.1 INTRODUCTION 94
TABLE 23 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 94
7.2 MEMBRANE-TO-MEMBRANE SYSTEMS 94
7.2.1 MEMBRANE-TO-MEMBRANE SYSTEMS PROVIDE A DOUBLE LAYER OF PROTECTION FOR THE SAFE TRANSFER OF HAZARDOUS DRUGS 94
TABLE 24 LEADING MANUFACTURERS OF MEMBRANE-TO-MEMBRANE SYSTEMS 94
TABLE 25 MEMBRANE-TO-MEMBRANE SYSTEMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 95
7.3 NEEDLELESS SYSTEMS 95
7.3.1 CHEMOLOCK IS THE FIRST FDA-APPROVED NEEDLELESS CSTD SYSTEM 95
TABLE 26 LEADING MANUFACTURERS OF NEEDLELESS SYSTEMS 96
TABLE 27 NEEDLELESS SYSTEMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 96

8 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT 97
8.1 INTRODUCTION 98
TABLE 28 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 98
8.2 VIAL ACCESS DEVICES 98
8.2.1 INCREASING REGULATORY COMPLIANCE TO DRIVE THE ADOPTION OF VIAL ACCESS DEVICES IN HOSPITALS & ONCOLOGY CENTERS 98
TABLE 29 VIAL ACCESS COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 99
TABLE 30 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR VIAL ACCESS DEVICES, BY COUNTRY, 2019-2026 (USD MILLION) 100
8.3 SYRINGE SAFETY DEVICES 100
8.3.1 ADVANTAGES SUCH AS EASE OF USE AND LEAK PREVENTION ARE DRIVING THE ADOPTION OF THESE DEVICES GLOBALLY 100
TABLE 31 SYRINGE SAFETY COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 101
TABLE 32 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR SYRINGE SAFETY DEVICES, BY COUNTRY, 2019-2026 (USD MILLION) 102
8.4 BAG/LINE ACCESS DEVICES 102
8.4.1 HIGH COMPATIBILITY OF BAG/LINE ACCESS DEVICES DRIVES MARKET GROWTH 102
TABLE 33 BAG/LINE ACCESS COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 103
TABLE 34 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR BAG/LINE ACCESS DEVICES, BY COUNTRY, 2019-2026 (USD MILLION) 104
8.5 ACCESSORIES 104
8.5.1 MAJOR CSTDS REQUIRE DEDICATED ADMINISTRATION SETS, WHICH DRIVES GROWTH IN THE ACCESSORIES MARKET 104
TABLE 35 ACCESSORIES FOR CLOSED SYSTEM TRANSFER DEVICES 105
TABLE 36 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR ACCESSORIES, BY COUNTRY, 2019-2026 (USD MILLION) 106

9 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY 107
9.1 INTRODUCTION 108
TABLE 37 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 108
9.2 DIAPHRAGM-BASED DEVICES 108
9.2.1 DIAPHRAGM-BASED DEVICES DOMINATE THE CLOSED SYSTEM TRANSFER DEVICES MARKET DUE TO THE EASE OF USE & SAFETY PROVIDED DURING THE HANDLING OF HAZARDOUS DRUGS 108
TABLE 38 DIAPHRAGM-BASED DEVICES AVAILABLE IN THE MARKET 108
TABLE 39 DIAPHRAGM-BASED CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 109
9.3 COMPARTMENTALIZED DEVICES 109
9.3.1 COMPARTMENTALIZED DEVICES TO WITNESS THE HIGHEST GROWTH IN THE MARKET DURING THE FORECAST PERIOD 109
TABLE 40 COMPARTMENTALIZED DEVICES AVAILABLE IN THE MARKET 110
TABLE 41 COMPARTMENTALIZED CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 110
9.4 AIR CLEANING/FILTRATION DEVICES 111
9.4.1 AIR CLEANING DEVICES INCORPORATE AN ACTIVATED CARBON OR HYDROPHOBIC FILTER TO HELP REDUCE THE OUTFLOW OF CONTAMINANTS 111
TABLE 42 AIR CLEANING/FILTRATION DEVICES AVAILABLE IN THE MARKET 111
TABLE 43 AIR CLEANING/FILTRATION CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 111

10 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER 112
10.1 INTRODUCTION 113
TABLE 44 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 113
10.2 HOSPITALS & CLINICS 113
10.2.1 HOSPITALS FORM THE LARGEST END-USER SEGMENT OF THE CLOSED SYSTEM TRANSFER DEVICES MARKET 113
TABLE 45 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019-2026 (USD MILLION) 114
10.3 ONCOLOGY CENTERS 114
10.3.1 INCREASING REGULATORY MANDATES TO DRIVE THE ADOPTION OF CSTDS IN ONCOLOGY CENTERS & CLINICS 114
TABLE 46 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR ONCOLOGY CENTERS, BY COUNTRY, 2019-2026 (USD MILLION) 115
10.4 OTHER END USERS 115
TABLE 47 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION) 116

11 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION 117
11.1 INTRODUCTION 118
FIGURE 35 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 118
TABLE 48 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION) 119
11.2 NORTH AMERICA 120
FIGURE 36 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT 120
TABLE 49 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 121
TABLE 50 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 121
TABLE 51 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 121
TABLE 52 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 122
TABLE 53 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 122
TABLE 54 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 122
11.2.1 US 123
11.2.1.1 US dominates the North American market primarily due to the presence of leading CSTD manufacturing companies & the high burden of cancer 123
TABLE 55 US: KEY MACROINDICATORS 124
TABLE 56 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 124
TABLE 57 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 124
TABLE 58 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 125
TABLE 59 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 125
TABLE 60 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 125
11.2.2 CANADA 126
11.2.2.1 Increasing prevalence of cancer to drive the growth of the Canadian market 126
TABLE 61 CANADA: KEY MACROINDICATORS 126
TABLE 62 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 127
TABLE 63 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 127
TABLE 64 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 127
TABLE 65 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 128
TABLE 66 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 128
11.3 EUROPE 128
FIGURE 37 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT 129
TABLE 67 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 130
TABLE 68 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 130
TABLE 69 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 130
TABLE 70 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 131
TABLE 71 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 131
TABLE 72 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 131
11.3.1 GERMANY 132
11.3.1.1 Germany to witness the highest growth in the European market 132
TABLE 73 GERMANY: KEY MACROINDICATORS 132
TABLE 74 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 133
TABLE 75 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 133
TABLE 76 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 133
TABLE 77 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 134
TABLE 78 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 134
11.3.2 UK 134
11.3.2.1 High cost of CSTDs to restrain the market growth 134
TABLE 79 UK: KEY MACROINDICATORS 135
TABLE 80 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 135
TABLE 81 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 135
TABLE 82 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 136
TABLE 83 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 136
TABLE 84 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 136
11.3.3 FRANCE 137
11.3.3.1 High cancer prevalence and the high healthcare expenditure in the country to drive market growth in France 137
TABLE 85 FRANCE: KEY MACROINDICATORS 137
TABLE 86 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 137
TABLE 87 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 138
TABLE 88 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 138
TABLE 89 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 138
TABLE 90 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 139
11.3.4 ITALY 139
11.3.4.1 Increasing geriatric population and the subsequent increase in the prevalence of cancer to drive the market for closed system transfer devices in Italy 139
TABLE 91 ITALY: KEY MACROINDICATORS 140
TABLE 92 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 140
TABLE 93 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 140
TABLE 94 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 141
TABLE 95 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 141
TABLE 96 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 141
11.3.5 SPAIN 142
11.3.5.1 Lack of specific regulations about CSTDs is restraining the growth of this market 142
TABLE 97 SPAIN: KEY MACROINDICATORS 142
TABLE 98 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 142
TABLE 99 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 143
TABLE 100 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 143
TABLE 101 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 143
TABLE 102 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 144
11.3.6 REST OF EUROPE 144
TABLE 103 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 145
TABLE 104 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 145
TABLE 105 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 145
TABLE 106 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 146
TABLE 107 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 146
11.4 ASIA PACIFIC 146
FIGURE 38 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT 147
TABLE 108 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION) 148
TABLE 109 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 148
TABLE 110 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 148
TABLE 111 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 149
TABLE 112 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 149
TABLE 113 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 149
11.4.1 JAPAN 150
11.4.1.1 Japan to dominate the APAC CSTDs market 150
TABLE 114 JAPAN: KEY MACROINDICATORS 151
TABLE 115 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 151
TABLE 116 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 151
TABLE 117 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 152
TABLE 118 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 152
TABLE 119 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 152
11.4.2 CHINA 153
11.4.2.1 The large patient pool provides significant growth opportunities in China 153
TABLE 120 CHINA: KEY MACROINDICATORS 153
TABLE 121 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 154
TABLE 122 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 154
TABLE 123 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 154
TABLE 124 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 155
TABLE 125 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 155
11.4.3 INDIA 155
11.4.3.1 Low manufacturing costs and skilled workforce are attracting outsourcing and investment to India 155
TABLE 126 INDIA: KEY MACROINDICATORS 156
TABLE 127 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 156
TABLE 128 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 156
TABLE 129 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 157
TABLE 130 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 157
TABLE 131 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 157
11.4.4 REST OF APAC 158
TABLE 132 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 158
TABLE 133 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 158
TABLE 134 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 159
TABLE 135 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 159
TABLE 136 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 159
11.5 LATIN AMERICA 160
11.5.1 RISING CANCER INCIDENCE TO DRIVE MARKET GROWTH IN LATAM 160
TABLE 137 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 160
TABLE 138 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 160
TABLE 139 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 161
TABLE 140 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 161
TABLE 141 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 161
11.6 MIDDLE EAST AND AFRICA 162
11.6.1 MEA MARKET TO GROW AT A SLOWER RATE THAN LATIN AMERICA 162
TABLE 142 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION) 162
TABLE 143 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION) 162
TABLE 144 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION) 163
TABLE 145 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION) 163
TABLE 146 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION) 163

12 COMPETITIVE LANDSCAPE 164
12.1 OVERVIEW 164
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 164
FIGURE 39 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE CLOSED SYSTEM TRANSFER DEVICE MARKET 165
12.3 REVENUE SHARE ANALYSIS 166
12.3.1 REVENUE ANALYSIS FOR KEY PLAYERS IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET 166
FIGURE 40 REVENUE ANALYSIS FOR KEY PLAYERS IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET IN THE PAST FIVE YEARS 166
12.4 MARKET SHARE ANALYSIS 167
12.4.1 CLOSED SYSTEM TRANSFER DEVICES MARKET (2020) 167
FIGURE 41 SHARE OF LEADING COMPANIES IN THE GLOBAL CLOSED SYSTEM TRANSFER DEVICES MARKET (2020) 167
TABLE 147 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEGREE OF COMPETITION 168
12.5 R&D ASSESSMENT OF KEY PLAYERS 168
12.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 169
12.7 COMPANY EVALUATION QUADRANT 170
12.7.1 COMPANY EVALUATION QUADRANT: CLOSED SYSTEM TRANSFER DEVICES MARKET 170
12.7.1.1 Stars 170
12.7.1.2 Pervasive players 170
12.7.1.3 Emerging leaders 170
12.7.1.4 Participants 170
FIGURE 42 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY EVALUATION MATRIX, 2020 171
12.8 COMPETITIVE BENCHMARKING 172
12.8.1 OVERALL COMPANY FOOTPRINT 172
TABLE 148 OVERALL COMPANY FOOTPRINT (20 COMPANIES) 172
TABLE 149 COMPANY FOOTPRINT: BY CLOSING MECHANISM (20 COMPANIES) 173
TABLE 150 COMPANY FOOTPRINT: BY TYPE (20 COMPANIES) 174
TABLE 151 COMPANY FOOTPRINT: BY COMPONENT (20 COMPANIES) 175
TABLE 152 COMPANY FOOTPRINT: BY TECHNOLOGY (20 COMPANIES) 176
TABLE 153 COMPANY FOOTPRINT: BY END USER (20 COMPANIES) 177
TABLE 154 COMPANY FOOTPRINT: BY REGION (20 COMPANIES) 178
12.9 COMPETITIVE SITUATIONS AND TRENDS 179
12.9.1 PRODUCT LAUNCHES & APPROVALS 179
TABLE 155 PRODUCT LAUNCHES & APPROVALS (2018-MAY 2021) 179
12.9.2 DEALS 179
TABLE 156 DEALS (2018-MAY 2021) 179
12.9.3 OTHER DEVELOPMENTS 180
TABLE 157 OTHER DEVELOPMENTS (2018-MAY 2021) 180

13 COMPANY PROFILES 181
13.1 KEY PLAYERS 181
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)* 13.1.1 BECTON, DICKINSON AND COMPANY 181
TABLE 158 BD: BUSINESS OVERVIEW 181
FIGURE 43 BD: COMPANY SNAPSHOT 182
13.1.2 ICU MEDICAL 185
TABLE 159 ICU MEDICAL: BUSINESS OVERVIEW 185
FIGURE 44 ICU MEDICAL: COMPANY SNAPSHOT 186
13.1.3 EQUASHIELD 189
TABLE 160 EQUASHIELD: BUSINESS OVERVIEW 189
13.1.4 B. BRAUN MELSUNGEN 192
TABLE 161 B. BRAUN MELSUNGEN: BUSINESS OVERVIEW 192
FIGURE 45 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT 193
13.1.5 JMS 195
TABLE 162 JMS: BUSINESS OVERVIEW 195
FIGURE 46 JMS: COMPANY SNAPSHOT 195
13.1.6 BAXTER INTERNATIONAL 197
TABLE 163 BAXTER INTERNATIONAL.: BUSINESS OVERVIEW 197
FIGURE 47 BAXTER INTERNATIONAL: COMPANY SNAPSHOT 198
13.1.7 SIMPLIVIA HEALTHCARE 200
TABLE 164 SIMPLIVIA HEALTHCARE: BUSINESS OVERVIEW 200
13.1.8 CORVIDA MEDICAL 202
TABLE 165 CORVIDA MEDICAL: BUSINESS OVERVIEW 202
13.1.9 YUKON MEDICAL 203
TABLE 166 YUKON MEDICAL: BUSINESS OVERVIEW 203
13.1.10 CODAN MEDIZINISCHE GERÄTE 205
TABLE 167 CODAN MEDIZINISCHE GERÄTE: BUSINESS OVERVIEW 205
13.1.11 VICTUS 207
TABLE 168 VICTUS: BUSINESS OVERVIEW 207
13.1.12 CARAGEN 208
TABLE 169 CARAGEN: BUSINESS OVERVIEW 208
13.2 OTHER PLAYERS 209
13.2.1 WEST PHARMACEUTICALS SERVICES 209
TABLE 170 WEST PHARMACEUTICALS SERVICES: BUSINESS OVERVIEW 209
FIGURE 48 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT (2020) 210
13.2.2 VYGON SA 212
TABLE 171 VYGON: BUSINESS OVERVIEW 212
13.2.3 PRACTIVET 213
TABLE 172 PRACTIVET: BUSINESS OVERVIEW 213
13.2.4 CORNING INCORPORATED 214
TABLE 173 CORNING INCORPORATED: BUSINESS OVERVIEW 214
FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2020) 215
13.2.5 TERUMO CORPORATION 216
TABLE 174 TERUMO CORPORATION: BUSINESS OVERVIEW 216
FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT 217
13.2.6 CARDINAL HEALTH 219
TABLE 175 CARDINAL HEALTH: BUSINESS OVERVIEW 219
FIGURE 51 CARDINAL HEALTH: COMPANY SNAPSHOT 220
13.2.7 ERASER MEDICAL 222
TABLE 176 ERASER MEDICAL: BUSINESS OVERVIEW 222
13.2.8 INSUNG MEDICAL 223
TABLE 177 INSUNG MEDICAL: BUSINESS OVERVIEW 223
13.2.9 NEEDLELESS CORPORATION 224
13.2.10 ADVCARE MEDICAL 225
13.2.11 ELCAM MEDICAL 226
13.2.12 EPIC MEDICAL 227
13.2.13 EDGE PHARMA 228
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies. 14 APPENDIX 229
14.1 DISCUSSION GUIDE 229
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 233
14.3 AVAILABLE CUSTOMIZATIONS 235
14.4 RELATED REPORTS 235
14.5 AUTHOR DETAILS 236